Back to the list
Congress: ECR25
Poster Number: C-11286
Type: Poster: EPOS Radiologist (scientific)
DOI: 10.26044/ecr2025/C-11286
Authorblock: S. V. Moreira1, G. Torri2, M. D. C. Fagundes3, M. L. R. Defante4, T. D. G. O. D. A. De Paulo3, M. A. Maria Da Silva5, R. E. Noleto Da Nobrega Oliveira6, D. d. O. S. Ramos7, B. Hochhegger8; 1Juiz de Fora, MG/BR, 2Santa Maria, RS/BR, 3São Paulo, SP/BR, 4Itaperuna RJ/BR, 5Novo Hamburgo, RS/BR, 6Barretos, SP/BR, 7São Paulo/BR, 8Gainesville, FL/US
Disclosures:
Sarah Verdan Moreira: Nothing to disclose
Giovanni Torri: Nothing to disclose
Marilia Da Cruz Fagundes: Nothing to disclose
Maria L. R. Defante: Nothing to disclose
Thiago De Gaultier Oliveira Do Amarante De Paulo: Nothing to disclose
Meiri Andréia Maria Da Silva: Nothing to disclose
Rachid Eduardo Noleto Da Nobrega Oliveira: Nothing to disclose
Danilo de Oliveira Santana Ramos: Nothing to disclose
Bruno Hochhegger: Nothing to disclose
Keywords: Mediastinum, Thorax, MR, Efficacy studies, Outcomes analysis, Statistics, Hyperplasia / Hypertrophy, Neoplasia, Outcomes
References

Joubert V, Chalabreysse L, Gamondes D, et al (2022) Clinical practices for non-neoplastic thymic lesions: Results from a multidisciplinary cohort. Lung Cancer 166:76–83. https://doi.org/10.1016/j.lungcan.2022.02.004

Priola AM, Priola SM, Gned D, et al (2016) Comparison of CT and chemical-shift MRI for differentiating thymoma from non-thymomatous conditions in myasthenia gravis: value of qualitative and quantitative assessment. Clin Radiol 71:e157–e169. https://doi.org/10.1016/j.crad.2015.12.009

Inaoka T, Takahashi K, Mineta M, et al (2007) Thymic Hyperplasia and Thymus Gland Tumors: Differentiation with Chemical Shift MR Imaging 1. Radiology 243:869–876. https://doi.org/10.1148/radiol.2433060797

Shetty AS, Sipe AL, Zulfiqar M, et al (2019) In-Phase and Opposed-Phase Imaging: Applications of Chemical Shift and Magnetic Susceptibility in the Chest and Abdomen. RadioGraphics 39:115–135. https://doi.org/10.1148/rg.2019180043

Popa GA, Preda EM, Scheau C, et al (2012) Updates in MRI characterization of the thymus in myasthenic patients. J Med Life Jun 12;5(2):206-10:

Takahashi K, Inaoka T, Murakami N, et al (2003) Characterization of the Normal and Hyperplastic Thymus on Chemical-Shift MR Imaging. American Journal of Roentgenology 180:1265–1269. https://doi.org/10.2214/ajr.180.5.1801265

Tuan PA, Vien M Van, Dong H Van, et al (2019) The Value of CT and MRI for Determining Thymoma in Patients With Myasthenia Gravis. Cancer Control 26:. https://doi.org/10.1177/1073274819865281

Priola AM, Priola SM, Ciccone G, et al (2015) Differentiation of Rebound and Lymphoid Thymic Hyperplasia from Anterior Mediastinal Tumors with Dual-Echo Chemical-Shift MR Imaging in Adulthood: Reliability of the Chemical-Shift Ratio and Signal Intensity Index. Radiology 274:238–249. https://doi.org/10.1148/radiol.14132665

Anh Tuan P, Minh Duc N (2022) The efficiency of chemical-shift MRI for the evaluation of thymoma in patients with myasthenia gravis. Clin Ter 572–575

Li K, Yang D-W, Hou S-F, et al (2014) Chemical Shift and Fat Suppression Magnetic Resonance Imaging of Thymus in Myasthenia Gravis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 41:782–786. https://doi.org/10.1017/cjn.2014.104

Priola AM, Priola SM, Giraudo MT, et al (2015) Chemical-Shift and Diffusion-Weighted Magnetic Resonance Imaging of Thymus in Myasthenia Gravis. Invest Radiol 50:228–238. https://doi.org/10.1097/RLI.0000000000000120

Priola AM, Gned D, Veltri A, Priola SM (2016) Chemical shift and diffusion-weighted magnetic resonance imaging of the anterior mediastinum in oncology: Current clinical applications in qualitative and quantitative assessment. Crit Rev Oncol Hematol 98:335–357. https://doi.org/10.1016/j.critrevonc.2015.11.012

Page MJ, McKenzie JE, Bossuyt PM, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ n71. https://doi.org/10.1136/bmj.n71

Salameh J-P, Bossuyt PM, McGrath TA, et al (2020) Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist. BMJ m2632. https://doi.org/10.1136/bmj.m2632

Bossuyt PM, Deeks JJ, Leeflang MM, et al (2023) Evaluating medical tests: introducing the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Cochrane Database of Systematic Reviews 2023:. https://doi.org/10.1002/14651858.ED000163

Whiting PF (2011) QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies. Ann Intern Med 155:529. https://doi.org/10.7326/0003-4819-155-8-201110180-00009

Balduzzi S, Rücker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evidence Based Mental Health 22:153–160. https://doi.org/10.1136/ebmental-2019-300117

Reitsma JB, Glas AS, Rutjes AWS, et al (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982–990. https://doi.org/10.1016/j.jclinepi.2005.02.022

Taymour TA, Soliman ES, Al-Sayyad EH, Tadros SF (2022) Can MRI chemical shift imaging replace thymic biopsy in myasthenia gravis patients? Egyptian Journal of Radiology and Nuclear Medicine 53:44. https://doi.org/10.1186/s43055-022-00717-z

 

 

 

 
GALLERY